Imre Noth, MD
Enriched profileDudley F. Rochester Professor of Medicine and Chief of the Division of Pulmonary and Critical Care Medicine · University of Virginia School of Medicine
Imre Noth is Dudley F. Rochester Professor of Medicine and Chief of the Division of Pulmonary and Critical Care Medicine at University of Virginia School of Medicine. OpenAlex indexes 383 publications with 16,369 citations (h-index 64); ClinicalTrials.gov lists 8 registered studies with this person as an investigator. By OpenAlex citation count, this profile ranks in the top 5% of Pulmonary Disease profiles in the findmyKOL directory.
Data verified 18 Oct 2026
Overview
Updated 18 Oct 2026
Imre Noth, MD, is Dudley F. Rochester Professor of Medicine and Chief of the Division of Pulmonary and Critical Care Medicine at University of Virginia School of Medicine. The public record shows 383 publications with 16,369 citations (h-index 64), centered on Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis, Occupational and environmental lung diseases, Chronic Obstructive Pulmonary Disease (COPD) Research. It also documents an investigator role on 8 registered clinical trials, industry payments reported by 8 companies, 2 NIH-funded awards (2018–2026).
- Most recent indexed publication: 2026 · American journal of respiratory and critical care medicine
- Top research focus: Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
- 8 registered trials on ClinicalTrials.gov
- Open Payments reporting from 8 companies
Generated from the cited public record · current as of 18 Oct 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintDrugs & molecules
across trials, industry payments and publicationsWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID; 15 in PubMed.
Total citations across indexed works.
Hirsch index (OpenAlex). i10-index 150.
Clinical & industry
trials, payments and federal fundingPublic positions
sourced statements on record- Chief of the Division of Pulmonary and Critical Care Medicine
University of Virginia
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →med.virginia.edu ↗
Contact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
Updated 18 Oct 2026
Listed as an investigator on 8 registered studies on ClinicalTrials.gov. The most recent:
- PRospective phenotypIng and Multi-omic Endotyping of Progressive Pulmonary Fibrosis
Sponsor: University of Massachusetts, Worcester
- The Role of Quantitative CT and Radiomic Biomarkers for Precision Medicine in Pulmonary Fibrosis
Sponsor: University of Virginia
- University of Virginia Natural History Study
Sponsor: University of Virginia
Industry payments
Updated 18 Oct 2026
8 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:
- Boehringer Ingelheim Pharmaceuticals, Inc.Program year202520 payments$15,619openpaymentsdata.cms.gov ↗
- United Therapeutics CorporationProgram year20253 payments$13,301openpaymentsdata.cms.gov ↗
- GENZYME CORPORATIONProgram year20251 payment$12,231openpaymentsdata.cms.gov ↗
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cancer & immunology
74%Kinase inhibitor51%Ofev100%Part D<11 patientsPyridone23.1%Pirfenidone100%Part D<11 patientsMetabolism & gastrointestinal
26%Corticosteroid26%Prednisone100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
Updated 18 Oct 2026
2 NIH research awards on record, funded 2018–2026 per NIH RePORTER. The latest:
- The role of quantitative CT and radiomic biomarkers for precision medicine in pulmonary fibrosis
University of Virginia
FY2026$716,889R01HL171918 - 1/2 Prospective tReatment EffiCacy in IPF uSlng genOtype for Nac Selection (PRECISIONS) trial and Molecular Endophenotyping in Idiopathic Pulmonary Fibrosis and Interstitial Lung Diseases study
Univ of Massachusetts Med Sch Worcester
FY2025$1,085,815UH3HL145266 - The role of quantitative CT and radiomic biomarkers for precision medicine in pulmonary fibrosis
University of Virginia
FY2025$731,520R01HL171918
Publications
Updated 18 Oct 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
- Reply to Fiorentù et al.: Lymphoid follicles in the lung complement lymph node activation in IPF.
American journal of respiratory and critical care medicine
Article2026 - Active Antigen-Specific Adaptive Immune Responses Are Shared among Patients with Progressive Fibrotic Interstitial Lung Disease.
American journal of respiratory and critical care medicine
Article2025 - Preacinar Arterial Dilation Mediates Outcomes of Quantitative Interstitial Abnormalities in the COPDGene Study.
American journal of respiratory and critical care medicine
Article2024 - Reply to van der Sar et al.: Classifying Interstitial Lung Disease: Omics Are in the Air.
American journal of respiratory and critical care medicine
Letter2024
Most-cited works
by citation count (OpenAlex)- 01Acute Exacerbations of Idiopathic Pulmonary FibrosisArticle1,129 citations2007
- 02
- 03
- 04Churg-Strauss syndromeArticle527 citations2003
- 05Association Between Telomere Length and Risk of Cancer and Non-Neoplastic DiseasesArticle513 citations2017
Network
Updated 18 Oct 2026
The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.
Online presence
Updated 18 Oct 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Owned accounts
public accounts run by this person- Doximity
doximity.com/pub/imre-noth-md
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →doximity.com ↗
Mentions by others
where others cite or feature them- Other
uvahealth.com/providers/Imre-Noth-1730241282
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →uvahealth.com ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Background & recognition
Updated 18 Oct 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →med.virginia.edu ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →med.virginia.edu ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →med.virginia.edu ↗
Editorial & leadership roles
journal and society appointments- Member
American Thoracic Society
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →expertinstitute.com ↗ - Member
American College of Chest Physicians
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →expertinstitute.com ↗
Secondary affiliations
appointments beyond the home institution- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →med.virginia.edu ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
William Petri, MD
University of Virginia School of Medicine
Robert Dreicer, MD
University of Virginia School of Medicine
Antonio Abbate, MD
University of Virginia School of Medicine
Craig Slingluff, MD
University of Virginia School of Medicine
Fernando Martinez, MD
University of Massachusetts Chan Medical School
David Gozal, MD
Ronald Crystal, MD
Weill Cornell Medicine
Bartolome Celli, MD
Brigham and Women's Hospital